Literature DB >> 24812285

JNK-dependent downregulation of FoxO1 is required to promote the survival of fibroblast-like synoviocytes in rheumatoid arthritis.

Aleksander M Grabiec1, Chiara Angiolilli1, Linda M Hartkamp1, Lisa G M van Baarsen1, Paul P Tak2, Kris A Reedquist1.   

Abstract

BACKGROUND: Forkhead box O (FoxO) transcription factors integrate environmental signals to modulate cell proliferation and survival, and alterations in FoxO function have been reported in rheumatoid arthritis (RA).
OBJECTIVES: To examine the relationship between inflammation and FoxO expression in RA, and to analyse the mechanisms and biological consequences of FoxO regulation in RA fibroblast-like synoviocytes (FLS).
METHODS: RNA was isolated from RA patient and healthy donor (HD) peripheral blood and RA synovial tissue. Expression of FoxO1, FoxO3a and FoxO4 was measured by quantitative PCR. FoxO1 DNA binding, expression and mRNA stability in RA FLS were measured by ELISA-based assays, immunoblotting and quantitative PCR. FLS were transduced with adenovirus encoding constitutively active FoxO1 (FoxO1ADA) or transfected with small interfering RNA targeting FoxO1 to examine the effects on cell viability and gene expression.
RESULTS: FoxO1 mRNA levels were reduced in RA patient peripheral blood compared with HD blood, and RA synovial tissue FoxO1 expression correlated negatively with disease activity. RA FLS stimulation with interleukin 1β or tumour necrosis factor caused rapid downregulation of FoxO1. This effect was independent of protein kinase B (PKB), but dependent on c-Jun N-terminal kinase (JNK)-mediated acceleration of FoxO1 mRNA degradation. FoxO1ADA overexpression in RA FLS induced apoptosis associated with altered expression of genes regulating cell cycle and survival, including BIM, p27(Kip1) and Bcl-XL.
CONCLUSIONS: Our findings identify JNK-dependent modulation of mRNA stability as an important PKB-independent mechanism underlying FoxO1 regulation by cytokines, and suggest that reduced FoxO1 expression is required to promote FLS survival in RA. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Cytokines; Fibroblasts; Inflammation; Rheumatoid Arthritis

Mesh:

Substances:

Year:  2014        PMID: 24812285     DOI: 10.1136/annrheumdis-2013-203610

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

Review 1.  Regulation of fibroblast-like synoviocyte transformation by transcription factors in arthritic diseases.

Authors:  Pallavi Bhattaram; Kyle Jones
Journal:  Biochem Pharmacol       Date:  2019-03-13       Impact factor: 5.858

Review 2.  The genetics revolution in rheumatology: large scale genomic arrays and genetic mapping.

Authors:  Stephen Eyre; Gisela Orozco; Jane Worthington
Journal:  Nat Rev Rheumatol       Date:  2017-06-01       Impact factor: 20.543

3.  Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Induces Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes.

Authors:  Hui Chen; Jing Pan; Jin-Dan Wang; Qiu-Mei Liao; Xiao-Ru Xia
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

4.  β-Ecdysone attenuates cartilage damage in a mouse model of collagenase-induced osteoarthritis via mediating FOXO1/ADAMTS-4/5 signaling axis.

Authors:  Junzhu Han; Jianzhong Guan; Xunbing Zhu
Journal:  Histol Histopathol       Date:  2021-04-20       Impact factor: 2.303

Review 5.  The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer.

Authors:  Manel B Hammouda; Amy E Ford; Yuan Liu; Jennifer Y Zhang
Journal:  Cells       Date:  2020-04-02       Impact factor: 6.600

6.  Control of cytokine mRNA degradation by the histone deacetylase inhibitor ITF2357 in rheumatoid arthritis fibroblast-like synoviocytes: beyond transcriptional regulation.

Authors:  Chiara Angiolilli; Pawel A Kabala; Aleksander M Grabiec; Marzia Rossato; Wi S Lai; Gianluca Fossati; Paolo Mascagni; Christian Steinkühler; Perry J Blackshear; Kris A Reedquist; Dominique L Baeten; Timothy R D J Radstake
Journal:  Arthritis Res Ther       Date:  2018-07-20       Impact factor: 5.156

7.  FoxO transcription factors modulate autophagy and proteoglycan 4 in cartilage homeostasis and osteoarthritis.

Authors:  Tokio Matsuzaki; Oscar Alvarez-Garcia; Sho Mokuda; Keita Nagira; Merissa Olmer; Ramya Gamini; Kohei Miyata; Yukio Akasaki; Andrew I Su; Hiroshi Asahara; Martin K Lotz
Journal:  Sci Transl Med       Date:  2018-02-14       Impact factor: 17.956

8.  Capture Hi-C reveals novel candidate genes and complex long-range interactions with related autoimmune risk loci.

Authors:  Paul Martin; Amanda McGovern; Gisela Orozco; Kate Duffus; Annie Yarwood; Stefan Schoenfelder; Nicholas J Cooper; Anne Barton; Chris Wallace; Peter Fraser; Jane Worthington; Steve Eyre
Journal:  Nat Commun       Date:  2015-11-30       Impact factor: 14.919

9.  αMSH inhibits adipose inflammation via reducing FoxOs transcription and blocking Akt/JNK pathway in mice.

Authors:  Guannv Liu; Meihang Li; Muhammad Saeed; Yatao Xu; Qian Ren; Chao Sun
Journal:  Oncotarget       Date:  2017-07-18

Review 10.  Rheumatoid Arthritis, Immunosenescence and the Hallmarks of Aging.

Authors:  Paulina Chalan; Anke van den Berg; Bart-Jan Kroesen; Liesbeth Brouwer; Annemieke Boots
Journal:  Curr Aging Sci       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.